| Connect Hearing, Inc. | |
|
4725 Hoen Ave, Ste B, Santa Rosa, CA 95405-9402 | |
| (707) 542-1154 | |
| (707) 542-1154 |
| Full Name | Connect Hearing, Inc. |
|---|---|
| Type | Facility |
| Speciality | Hearing Aid Equipment |
| Location | 4725 Hoen Ave, Santa Rosa, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740533678 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Connect Hearing, Inc. 750 N Commons Dr Ste 200, Aurora, IL 60504-7940 Ph: (630) 303-5380 | Connect Hearing, Inc. 4725 Hoen Ave, Ste B, Santa Rosa, CA 95405-9402 Ph: (707) 542-1154 |
News Archive
The passage of sweeping healthcare legislation and the recent election of the 112th Congress make these exciting but uncertain times for American healthcare. The National Quality Forum's annual conference, "Achieving Health of Individuals and Populations Within Their Communities," will focus on population health and bring together policymakers and key public- and private-sector stakeholders, each representing their own perspectives for improving health and healthcare throughout the country.
National Institute of Standards and Technology researchers at the Institute for Bioscience and Biotechnology Research have demonstrated the most precise method yet to measure the structural configuration of monoclonal antibodies (mAbs), an important factor in determining the safety and efficacy of these biomolecules as medicines.
Pharmaceutical drugs approved by the Food and Drug Administration (FDA) but later re-called from the market-such as the antidiabetic drug Avandia and pain-reliever Vioxx-were the impetus for an Institute of Medicine committee report released yesterday, recommending that the FDA take proactive steps to continue monitoring drugs' safety after initial approval and throughout their time on the market.
Researchers from Salk have found that two experimental drugs named CMS121 and J147 may improve memory functions and reduce the progression of memory decline and brain degeneration in mice models of Alzheimer's disease (AD). The researchers published their work in the latest issue of the journal eLife. The study was titled, "Elevating acetyl-CoA levels reduces aspects of brain aging."
› Verified 2 days ago